Bio-Gene Technology Ltd. (AU:BGT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bio-Gene Technology Ltd. is advancing towards the regulatory approval of Flavocide®, a nature-derived insecticidal active ingredient, with positive feedback from the Australian Pesticides and Veterinary Medicines Authority (APVMA). The company is on schedule to submit the regulatory dossier by the end of 2025, following APVMA’s guidance on the required studies for its application, ensuring the development path is optimized. Flavocide promises to be a significant advancement in combating insecticide resistance in various sectors, including public health, agriculture, and consumer use.
For further insights into AU:BGT stock, check out TipRanks’ Stock Analysis page.